Progress Toward Identifying Exact Proxies for Predicting Response to Immunotherapies. https://t.co/q1kFT0NWVF
112 followers
257 followers
Progress Toward Identifying Exact Proxies for Predicting Response to Immunotherapies. https://t.co/vZvn09yQCo
4,275 followers
Our CSO Joe Bolen, Oncology Lead Aleksandra Filipovic & collaborator George Miller (NYU) summarized the progress of prognostic & predictive biomarker development & use in the era of #immunooncology in @FrontiersIn https://t.co/0xxr40ZQYu #Preci
3,906 followers
New Research: Progress Toward Identifying Exact Proxies for Predicting Response to Immunotherapies: Clinical value and utility of checkpoint inhibitors, a drug class targeting adaptive immune suppression pathways (PD-1, PDL-1, and CTLA-4), is… https://t.co